Human epidermal receptor 2-amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment-Reference-Cited by-同舟云学术

Human epidermal receptor 2-amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment

Published:2013-10-19 Issue:3 Volume:36 Page:E25-E27
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Falchook Gerald S.¹,Lippman Scott M.²,Bastida Christel C.¹,Kurzrock Razelle²

Affiliation:

1. Department of Investigational Cancer Therapeutics; (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center; Houston Texas

2. Moores Cancer Center; University of California, San Diego; La Jolla California

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.23429/fullpdf

Reference32 articles.

1. Salivary duct carcinoma: a report of nine cases;Colmenero Ruiz;J Oral Maxillofac Surg,1993

2. Systemic therapy in the palliative management of advanced salivary gland cancers;Laurie;J Clin Oncol,2006

3. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases;Lewis;Cancer,1996

4. Infiltrating salivary duct carcinoma. A clinicopathologic study of five cases;Chen;Arch Otolaryngol,1981

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic characteristics of a highly metastatic basal cell adenocarcinoma arising in buccal mucosa;Oral Oncology;2024-02

2. HER2-targeted therapies for salivary gland cancers;Oral Oncology;2024-01

3. ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy;Modern Pathology;2023-10

4. Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors;Biomedicines;2023-02-10

5. ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing;Modern Pathology;2021-12-28